SEARCH FOR A SPECIFIC TOPIC
Tags Compulsory license

Tag: compulsory license

December 14, 2020
|

Pandemics, Public Interest and Patent Infringement in I...

In patent law, there is a constant tug of war between the importance of incentivizing innovators and the need to ensure that consumers have access to innovations. The law reflects this tussle as well. But this constant striving to balance the rights between patentees and consumers is essential for the patent system to function and be meaningful to society. ......
May 1, 2020
|

Overcoming Pandemic Profiteering in Times of Crisis

Today, as the global scientific and research community doubles down on finding a potential drug or vaccine against the novel Coronavirus, the obvious question that arises is of access to affordable drugs and medical equipment. With the high investment required in drug discovery and pharmaceutical research generally, the debate naturally turns to the returns on such investment in times of a public health crisis as the one being faced today. This note seeks to understand if intellectual property (IP) protection will be a barrier to affordable drugs....
October 14, 2019
|

Bolar provision remains standing after Bayer challenge

The Delhi High Court recently adjudicated on the issue of whether generic companies can export patented products for experimental purpose, in an expansive interpretation of Section 107A of the Indian Patents Act, 1970 (the ‘Act’). Section 107A, which relates to what is referred to as ‘the Bolar Provision’, was introduced via the Patents Act (Second Amendment) Bill, 1999. The provision sought to ensure the prompt availability of patented products, particularly generic drugs, immediately after the expiry of the patent term....
March 7, 2019
|

Expert evidence is essential for a patent challenge

The Madras High Court earlier this year rejected a writ petition filed against a patent owned by Kibow Biotech Inc. for a dietary supplement that aids in the carrying out of the kidney function, for reasons, among others, that there was no expert evidence led to support the case. The validity of the patent was challenged primarily under Section 3(e) of the Patents Act, i.e., on grounds that it was “a substance obtained by a mere admixture resulting only in the aggregation of the properties of the components thereof or a process for producing such substance”....

The DPIIT Working Paper on AI and Copyright: Regulatory Signals and Practical Implications...

Artificial intelligence ("AI") is no longer at the margins of business strategy. For many organisations, it has become embedded in product design, customer engagement, internal workflows and long-term planning...

Vague Definitions, Harsh Penalties and Constitutional Incompatibility: Why the Karnataka H...

On December 10, 2025, the Government of Karnataka tabled the Karnataka Hate Speech and Hate Crimes (Prevention) Bill, 2025 (the "Bill") to prevent dissemination and punish perpetrators of hate speech and hate crimes...

Broadening the Small Company Net: Implications of the New Threshold

On December 1, 2025, the Ministry of Corporate Affairs ("MCA") via Notification G.S.R. 880(E) ("Notification"), introduced pivotal amendment to the definition of a "Small Company" under Sec-tion 2(85) of the Companies Act...

Privacy at the Price of Transparency: Legal Implications of the Amendments to Section 8 of...

The Ministry of Electronics and Information Technology ("MeitY") recently notified the Digital Personal Data Protection Rules, 2025, on November 14, 2025. This notification brings into force the Digital Personal...

Recalibrating Corporate Governance: An Analysis of the SEBI LODR 5th Amendment, 2025

On November 19, 2025, the Securities and Exchange Board of India ("SEBI") notified the fifth amendment to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations...

Drafting deepfake defences: comments on India’s proposed amendments to the IT Rules

On October 22, 2025, the Ministry of Electronics and Information Technology ("MeitY") proposed significant amendments ("Proposed Amendments") to the Information...

Formulation fight: Amgen case tests patentability of biopharmaceuticals in India

In a high-stakes case, the Madras High Court examines whether Amgen's specific formulation is non-obvious and patentable, and whether the prior art guides...

Implementation of India’s Four Labour Codes: Key Changes and the Road Ahead

On November 21, 2025, the Ministry of Labour and Employment issued notifications operationalizing substantial portions of India's four labour codes...

The Digital Personal Data Protection Rules, 2025: A New Digital Frontier

The Ministry of Information and Technology (“MeitY”) on Thursday, November 13, 2025 notified the Digital Personal Data Protection Rules, 2025 (the “DPDP Rules”), framed under the Digital Personal Data Protection Act, 2023 (the “DPDP Act”).

Indemnity and Limitation of Liability Clauses: Strategic Risk Allocation in Commercial Con...

In the world of commercial contracts, astute risk management is paramount. Among the arsenal of legal tools and safeguards available to parties, the indemnity and limitation...